Source: Resumos. Conference titles: World Congress on Psychiatric Genetics. Unidade: FM
Subjects: FARMACOGÉNITICA, DEPRESSÃO (TERAPIA;GENÉTICA), ANTIDEPRESSIVOS (USO TERAPÊUTICO), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADO, Carolina M. et al. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. 2008, Anais.. Osaka: Faculdade de Medicina, Universidade de São Paulo, 2008. p. 13. . Acesso em: 27 set. 2024.APA
Prado, C. M., Moreno, R. A., Gattaz, W. F., & Ojopi, E. P. B. (2008). Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. In Resumos (p. 13). Osaka: Faculdade de Medicina, Universidade de São Paulo.NLM
Prado CM, Moreno RA, Gattaz WF, Ojopi EPB. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. Resumos. 2008 ; 13.[citado 2024 set. 27 ]Vancouver
Prado CM, Moreno RA, Gattaz WF, Ojopi EPB. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. Resumos. 2008 ; 13.[citado 2024 set. 27 ]
